ID   PP2BA_HUMAN             Reviewed;         521 AA.
AC   Q08209; A1A441; A8K3B7; A8W6Z7; A8W6Z8; B5BUA2; Q8TAW9;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   10-MAY-2017, entry version 184.
DE   RecName: Full=Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform;
DE            EC=3.1.3.16;
DE   AltName: Full=CAM-PRP catalytic subunit;
DE   AltName: Full=Calmodulin-dependent calcineurin A subunit alpha isoform;
GN   Name=PPP3CA; Synonyms=CALNA, CNA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8392375; DOI=10.1016/0167-4889(93)90117-8;
RA   Muramatsu T., Kincaid R.L.;
RT   "Molecular cloning of a full-length cDNA encoding the catalytic
RT   subunit of human calmodulin-dependent protein phosphatase (calcineurin
RT   A alpha).";
RL   Biochim. Biophys. Acta 1178:117-120(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4), AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=20590401; DOI=10.3109/10826084.2010.482449;
RA   Chiocco M.J., Zhu X., Walther D., Pletnikova O., Troncoso J.C.,
RA   Uhl G.R., Liu Q.R.;
RT   "Fine mapping of calcineurin (PPP3CA) gene reveals novel alternative
RT   splicing patterns, association of 5'UTR trinucleotide repeat with
RT   addiction vulnerability, and differential isoform expression in
RT   Alzheimer's disease.";
RL   Subst. Use Misuse 45:1809-1826(2010).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RX   PubMed=21647268;
RA   Landreville S., Lupien C.B., Vigneault F., Gaudreault M., Mathieu M.,
RA   Rousseau A.P., Guerin S.L., Salesse C.;
RT   "Identification of differentially expressed genes in uveal melanoma
RT   using suppressive subtractive hybridization.";
RL   Mol. Vis. 17:1324-1333(2011).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   INTERACTION WITH MYOZ1 AND MYOZ2.
RX   PubMed=11114196; DOI=10.1073/pnas.260501097;
RA   Frey N., Richardson J.A., Olson E.N.;
RT   "Calsarcins, a novel family of sarcomeric calcineurin-binding
RT   proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:14632-14637(2000).
RN   [11]
RP   INTERACTION WITH MYOZ3.
RX   PubMed=11842093; DOI=10.1074/jbc.M200712200;
RA   Frey N., Olson E.N.;
RT   "Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin
RT   family, interacts with multiple Z-disc proteins.";
RL   J. Biol. Chem. 277:13998-14004(2002).
RN   [12]
RP   INTERACTION WITH CRTC2.
RX   PubMed=15454081; DOI=10.1016/j.cell.2004.09.015;
RA   Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G.,
RA   Jeffries S., Guzman E., Niessen S., Yates J.R. III, Takemori H.,
RA   Okamoto M., Montminy M.;
RT   "The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive
RT   coincidence detector.";
RL   Cell 119:61-74(2004).
RN   [13]
RP   FUNCTION.
RX   PubMed=15671020; DOI=10.1074/jbc.M411494200;
RA   Wang Y., Shibasaki F., Mizuno K.;
RT   "Calcium signal-induced cofilin dephosphorylation is mediated by
RT   Slingshot via calcineurin.";
RL   J. Biol. Chem. 280:12683-12689(2005).
RN   [14]
RP   INTERACTION WITH SYNPO2.
RX   PubMed=17923693; DOI=10.1128/MCB.00950-07;
RA   Faul C., Dhume A., Schecter A.D., Mundel P.;
RT   "Protein kinase A, Ca2+/calmodulin-dependent kinase II, and
RT   calcineurin regulate the intracellular trafficking of myopodin between
RT   the Z-disc and the nucleus of cardiac myocytes.";
RL   Mol. Cell. Biol. 27:8215-8227(2007).
RN   [15]
RP   INTERACTION WITH DMN1L, AND FUNCTION.
RX   PubMed=18838687; DOI=10.1073/pnas.0808249105;
RA   Cereghetti G.M., Stangherlin A., Martins de Brito O., Chang C.R.,
RA   Blackstone C., Bernardi P., Scorrano L.;
RT   "Dephosphorylation by calcineurin regulates translocation of Drp1 to
RT   mitochondria.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:15803-15808(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS).
RX   PubMed=8524402; DOI=10.1038/378641a0;
RA   Kissinger C.R., Parge H.E., Knighton D.R., Lewis C.T., Pelletier L.A.,
RA   Tempczyk A., Kalish V.J., Tucker K.D., Showalter R.E., Moomaw E.W.,
RA   Gastinel L.N., Habuka N., Chen X., Maldonado F., Barker J.E.,
RA   Bacquet R., Villafranca J.E.;
RT   "Crystal structures of human calcineurin and the human FKBP12-FK506-
RT   calcineurin complex.";
RL   Nature 378:641-644(1995).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-380 IN COMPLEX WITH
RP   SUBSTRATE PEPTIDE, FUNCTION, AND METAL-BINDING SITES.
RX   PubMed=17498738; DOI=10.1016/j.jmb.2007.04.032;
RA   Li H., Zhang L., Rao A., Harrison S.C., Hogan P.G.;
RT   "Structure of calcineurin in complex with PVIVIT peptide: portrait of
RT   a low-affinity signalling interaction.";
RL   J. Mol. Biol. 369:1296-1306(2007).
CC   -!- FUNCTION: Calcium-dependent, calmodulin-stimulated protein
CC       phosphatase. Many of the substrates contain a PxIxIT motif. This
CC       subunit may have a role in the calmodulin activation of
CC       calcineurin. Dephosphorylates DNM1L, HSPB1 and SSH1.
CC       {ECO:0000269|PubMed:15671020, ECO:0000269|PubMed:17498738,
CC       ECO:0000269|PubMed:18838687}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- COFACTOR:
CC       Name=Fe(3+); Xref=ChEBI:CHEBI:29034;
CC       Note=Binds 1 Fe(3+) ion per subunit.;
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 1 zinc ion per subunit.;
CC   -!- SUBUNIT: Interacts with CIB1; the interaction increases upon
CC       cardiomyocytes hypertrophy (By similarity). Interacts with CHP1
CC       and CHP2 (By similarity). Composed of two components (A and B),
CC       the A component is the catalytic subunit and the B component
CC       confers calcium sensitivity. Interacts with CRTC2, MYOZ1, MYOZ2
CC       and MYOZ3. Interacts with DNM1L; the interaction dephosphorylates
CC       DNM1L and regulates its translocation to mitochondria. Interacts
CC       with CMYA5; this interaction represses calcineurin activity in
CC       muscle (By similarity). Interacts (constitutively active form)
CC       with SYNPO2 (PubMed:17923693). {ECO:0000250,
CC       ECO:0000269|PubMed:17923693}.
CC   -!- INTERACTION:
CC       R4GN89:C16orf74; NbExp=3; IntAct=EBI-352922, EBI-10225238;
CC       Q8VHW5:Cacng8 (xeno); NbExp=2; IntAct=EBI-352922, EBI-9086576;
CC       P62993:GRB2; NbExp=3; IntAct=EBI-352922, EBI-401755;
CC       P63098:PPP3R1; NbExp=5; IntAct=EBI-352922, EBI-915984;
CC       P54578:USP14; NbExp=3; IntAct=EBI-352922, EBI-1048016;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}. Cell membrane,
CC       sarcolemma {ECO:0000250}. Nucleus {ECO:0000250}. Note=Colocalizes
CC       with ACTN1 and MYOZ2 at the Z line in heart and skeletal muscle.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q08209-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q08209-2; Sequence=VSP_018562;
CC       Name=3;
CC         IsoId=Q08209-3; Sequence=VSP_043378, VSP_018562;
CC       Name=4;
CC         IsoId=Q08209-4; Sequence=VSP_047755;
CC       Name=5;
CC         IsoId=Q08209-5; Sequence=VSP_054467;
CC   -!- SIMILARITY: Belongs to the PPP phosphatase family. PP-2B
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Calcineurin entry;
CC       URL="https://en.wikipedia.org/wiki/Calcineurin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L14778; AAA02631.1; -; mRNA.
DR   EMBL; EU192652; ABW74484.1; -; mRNA.
DR   EMBL; EU192653; ABW74485.1; -; mRNA.
DR   EMBL; AY904364; AAY17314.1; -; mRNA.
DR   EMBL; AK290532; BAF83221.1; -; mRNA.
DR   EMBL; AL353950; CAB89253.1; -; mRNA.
DR   EMBL; AB451338; BAG70152.1; -; mRNA.
DR   EMBL; AB451487; BAG70301.1; -; mRNA.
DR   EMBL; AC092671; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001816; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001870; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001939; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471057; EAX06125.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX06124.1; -; Genomic_DNA.
DR   EMBL; BC025714; AAH25714.1; -; mRNA.
DR   CCDS; CCDS34037.1; -. [Q08209-1]
DR   CCDS; CCDS47113.1; -. [Q08209-3]
DR   CCDS; CCDS47114.1; -. [Q08209-2]
DR   PIR; S35067; S35067.
DR   RefSeq; NP_000935.1; NM_000944.4. [Q08209-1]
DR   RefSeq; NP_001124163.1; NM_001130691.1. [Q08209-2]
DR   RefSeq; NP_001124164.1; NM_001130692.1. [Q08209-3]
DR   UniGene; Hs.435512; -.
DR   PDB; 1AUI; X-ray; 2.10 A; A=1-521.
DR   PDB; 1M63; X-ray; 2.80 A; A/E=1-372.
DR   PDB; 1MF8; X-ray; 3.10 A; A=20-392.
DR   PDB; 2JOG; NMR; -; A=21-347.
DR   PDB; 2JZI; NMR; -; B=391-414.
DR   PDB; 2P6B; X-ray; 2.30 A; A/C=1-380.
DR   PDB; 2R28; X-ray; 1.86 A; C/D=389-413.
DR   PDB; 2W73; X-ray; 1.45 A; K/L/M/O=395-411.
DR   PDB; 3LL8; X-ray; 2.00 A; A/C=14-370.
DR   PDB; 4F0Z; X-ray; 1.70 A; A=1-370.
DR   PDB; 4Q5U; X-ray; 1.95 A; C=391-414.
DR   PDB; 5C1V; X-ray; 3.35 A; A/B=2-346.
DR   PDB; 5SVE; X-ray; 2.60 A; A=1-370.
DR   PDBsum; 1AUI; -.
DR   PDBsum; 1M63; -.
DR   PDBsum; 1MF8; -.
DR   PDBsum; 2JOG; -.
DR   PDBsum; 2JZI; -.
DR   PDBsum; 2P6B; -.
DR   PDBsum; 2R28; -.
DR   PDBsum; 2W73; -.
DR   PDBsum; 3LL8; -.
DR   PDBsum; 4F0Z; -.
DR   PDBsum; 4Q5U; -.
DR   PDBsum; 5C1V; -.
DR   PDBsum; 5SVE; -.
DR   DisProt; DP00092; -.
DR   ProteinModelPortal; Q08209; -.
DR   SMR; Q08209; -.
DR   BioGrid; 111522; 58.
DR   DIP; DIP-6095N; -.
DR   IntAct; Q08209; 19.
DR   MINT; MINT-1037516; -.
DR   STRING; 9606.ENSP00000378323; -.
DR   BindingDB; Q08209; -.
DR   ChEMBL; CHEMBL4445; -.
DR   DrugBank; DB08231; MYRISTIC ACID.
DR   DEPOD; Q08209; -.
DR   iPTMnet; Q08209; -.
DR   PhosphoSitePlus; Q08209; -.
DR   SwissPalm; Q08209; -.
DR   BioMuta; PPP3CA; -.
DR   DMDM; 1352673; -.
DR   EPD; Q08209; -.
DR   MaxQB; Q08209; -.
DR   PaxDb; Q08209; -.
DR   PeptideAtlas; Q08209; -.
DR   PRIDE; Q08209; -.
DR   DNASU; 5530; -.
DR   Ensembl; ENST00000323055; ENSP00000320580; ENSG00000138814. [Q08209-3]
DR   Ensembl; ENST00000394853; ENSP00000378322; ENSG00000138814. [Q08209-2]
DR   Ensembl; ENST00000394854; ENSP00000378323; ENSG00000138814. [Q08209-1]
DR   Ensembl; ENST00000512215; ENSP00000422781; ENSG00000138814. [Q08209-4]
DR   GeneID; 5530; -.
DR   KEGG; hsa:5530; -.
DR   UCSC; uc003hvu.3; human. [Q08209-1]
DR   CTD; 5530; -.
DR   DisGeNET; 5530; -.
DR   GeneCards; PPP3CA; -.
DR   HGNC; HGNC:9314; PPP3CA.
DR   HPA; CAB018581; -.
DR   HPA; HPA012778; -.
DR   MIM; 114105; gene.
DR   neXtProt; NX_Q08209; -.
DR   OpenTargets; ENSG00000138814; -.
DR   PharmGKB; PA33678; -.
DR   eggNOG; KOG0375; Eukaryota.
DR   eggNOG; COG0639; LUCA.
DR   GeneTree; ENSGT00530000063087; -.
DR   HOGENOM; HOG000172699; -.
DR   HOVERGEN; HBG002819; -.
DR   InParanoid; Q08209; -.
DR   KO; K04348; -.
DR   OMA; ELICEGD; -.
DR   OrthoDB; EOG091G094R; -.
DR   PhylomeDB; Q08209; -.
DR   TreeFam; TF105557; -.
DR   Reactome; R-HSA-180024; DARPP-32 events.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-5607763; CLEC7A (Dectin-1) induces NFAT activation.
DR   SIGNOR; Q08209; -.
DR   ChiTaRS; PPP3CA; human.
DR   EvolutionaryTrace; Q08209; -.
DR   GeneWiki; PPP3CA; -.
DR   GenomeRNAi; 5530; -.
DR   PMAP-CutDB; Q08209; -.
DR   PRO; PR:Q08209; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000138814; -.
DR   CleanEx; HS_PPP3CA; -.
DR   ExpressionAtlas; Q08209; baseline and differential.
DR   Genevisible; Q08209; HS.
DR   GO; GO:0005955; C:calcineurin complex; IDA:CAFA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell.
DR   GO; GO:0030018; C:Z disc; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; NAS:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB.
DR   GO; GO:0033192; F:calmodulin-dependent protein phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0016018; F:cyclosporin A binding; IDA:CAFA.
DR   GO; GO:0008144; F:drug binding; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IDA:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IPI:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; NAS:UniProtKB.
DR   GO; GO:0033173; P:calcineurin-NFAT signaling cascade; IDA:BHF-UCL.
DR   GO; GO:0006816; P:calcium ion transport; IEA:Ensembl.
DR   GO; GO:0014898; P:cardiac muscle hypertrophy in response to stress; IEA:Ensembl.
DR   GO; GO:0035690; P:cellular response to drug; IDA:UniProtKB.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0016311; P:dephosphorylation; TAS:UniProtKB.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; IEA:Ensembl.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0050804; P:modulation of synaptic transmission; IEA:Ensembl.
DR   GO; GO:0033555; P:multicellular organismal response to stress; IEA:Ensembl.
DR   GO; GO:0035562; P:negative regulation of chromatin binding; IEA:Ensembl.
DR   GO; GO:0050774; P:negative regulation of dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl.
DR   GO; GO:1903799; P:negative regulation of production of miRNAs involved in gene silencing by miRNA; IEA:Ensembl.
DR   GO; GO:1903244; P:positive regulation of cardiac muscle hypertrophy in response to stress; IEA:Ensembl.
DR   GO; GO:1905205; P:positive regulation of connective tissue replacement; IEA:Ensembl.
DR   GO; GO:0051533; P:positive regulation of NFAT protein import into nucleus; IDA:BHF-UCL.
DR   GO; GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0006606; P:protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0001975; P:response to amphetamine; IEA:Ensembl.
DR   GO; GO:0051592; P:response to calcium ion; IDA:UniProtKB.
DR   GO; GO:0048741; P:skeletal muscle fiber development; IEA:Ensembl.
DR   GO; GO:0042110; P:T cell activation; TAS:UniProtKB.
DR   GO; GO:0014883; P:transition between fast and slow fiber; IEA:Ensembl.
DR   GO; GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; TAS:Reactome.
DR   Gene3D; 3.60.21.10; -; 1.
DR   InterPro; IPR004843; Calcineurin-like_PHP_ApaH.
DR   InterPro; IPR029052; Metallo-depent_PP-like.
DR   InterPro; IPR006186; Ser/Thr-sp_prot-phosphatase.
DR   Pfam; PF00149; Metallophos; 1.
DR   PRINTS; PR00114; STPHPHTASE.
DR   SMART; SM00156; PP2Ac; 1.
DR   SUPFAM; SSF56300; SSF56300; 1.
DR   PROSITE; PS00125; SER_THR_PHOSPHATASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Calmodulin-binding;
KW   Cell membrane; Complete proteome; Hydrolase; Iron; Membrane;
KW   Metal-binding; Nitration; Nucleus; Phosphoprotein;
KW   Protein phosphatase; Reference proteome; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    521       Serine/threonine-protein phosphatase 2B
FT                                catalytic subunit alpha isoform.
FT                                /FTId=PRO_0000058822.
FT   REGION        2    301       Catalytic.
FT   REGION      247    253       Calcineurin B binding-site 1.
FT                                {ECO:0000255}.
FT   REGION      296    301       Calcineurin B binding-site 2.
FT                                {ECO:0000255}.
FT   REGION      392    414       Calmodulin-binding. {ECO:0000255}.
FT   REGION      465    487       Inhibitory domain.
FT   ACT_SITE    151    151       Proton donor. {ECO:0000250}.
FT   METAL        90     90       Iron.
FT   METAL        92     92       Iron.
FT   METAL       118    118       Iron.
FT   METAL       118    118       Zinc.
FT   METAL       150    150       Zinc.
FT   METAL       199    199       Zinc.
FT   METAL       281    281       Zinc.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     224    224       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:P63328}.
FT   MOD_RES     469    469       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P63329}.
FT   MOD_RES     492    492       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      20     86       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:21647268}.
FT                                /FTId=VSP_054467.
FT   VAR_SEQ      87    318       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:20590401}.
FT                                /FTId=VSP_047755.
FT   VAR_SEQ     318    359       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:20590401}.
FT                                /FTId=VSP_043378.
FT   VAR_SEQ     448    457       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:20590401}.
FT                                /FTId=VSP_018562.
FT   STRAND       13     15       {ECO:0000244|PDB:5SVE}.
FT   HELIX        31     34       {ECO:0000244|PDB:4F0Z}.
FT   HELIX        43     51       {ECO:0000244|PDB:4F0Z}.
FT   HELIX        58     73       {ECO:0000244|PDB:4F0Z}.
FT   STRAND       77     81       {ECO:0000244|PDB:4F0Z}.
FT   STRAND       83     88       {ECO:0000244|PDB:4F0Z}.
FT   HELIX        95    105       {ECO:0000244|PDB:4F0Z}.
FT   TURN        108    110       {ECO:0000244|PDB:3LL8}.
FT   STRAND      113    115       {ECO:0000244|PDB:4F0Z}.
FT   STRAND      120    123       {ECO:0000244|PDB:4F0Z}.
FT   HELIX       126    139       {ECO:0000244|PDB:4F0Z}.
FT   TURN        141    143       {ECO:0000244|PDB:4F0Z}.
FT   STRAND      144    146       {ECO:0000244|PDB:4F0Z}.
FT   HELIX       154    159       {ECO:0000244|PDB:4F0Z}.
FT   HELIX       162    169       {ECO:0000244|PDB:4F0Z}.
FT   HELIX       172    183       {ECO:0000244|PDB:4F0Z}.
FT   STRAND      188    191       {ECO:0000244|PDB:4F0Z}.
FT   TURN        192    194       {ECO:0000244|PDB:4F0Z}.
FT   STRAND      195    200       {ECO:0000244|PDB:4F0Z}.
FT   STRAND      206    208       {ECO:0000244|PDB:2JOG}.
FT   HELIX       210    213       {ECO:0000244|PDB:4F0Z}.
FT   STRAND      218    220       {ECO:0000244|PDB:4F0Z}.
FT   STRAND      223    225       {ECO:0000244|PDB:4F0Z}.
FT   HELIX       226    232       {ECO:0000244|PDB:4F0Z}.
FT   TURN        237    240       {ECO:0000244|PDB:4F0Z}.
FT   STRAND      247    250       {ECO:0000244|PDB:4F0Z}.
FT   TURN        252    254       {ECO:0000244|PDB:4F0Z}.
FT   STRAND      255    260       {ECO:0000244|PDB:4F0Z}.
FT   HELIX       262    271       {ECO:0000244|PDB:4F0Z}.
FT   STRAND      276    279       {ECO:0000244|PDB:4F0Z}.
FT   STRAND      287    290       {ECO:0000244|PDB:4F0Z}.
FT   TURN        295    297       {ECO:0000244|PDB:4F0Z}.
FT   STRAND      298    306       {ECO:0000244|PDB:4F0Z}.
FT   HELIX       311    313       {ECO:0000244|PDB:4F0Z}.
FT   STRAND      319    325       {ECO:0000244|PDB:4F0Z}.
FT   STRAND      328    334       {ECO:0000244|PDB:4F0Z}.
FT   HELIX       344    346       {ECO:0000244|PDB:4F0Z}.
FT   HELIX       349    369       {ECO:0000244|PDB:4F0Z}.
FT   HELIX       396    409       {ECO:0000244|PDB:2W73}.
FT   HELIX       470    477       {ECO:0000244|PDB:1AUI}.
FT   HELIX       478    481       {ECO:0000244|PDB:1AUI}.
SQ   SEQUENCE   521 AA;  58688 MW;  16480D62DDBF1F40 CRC64;
     MSEPKAIDPK LSTTDRVVKA VPFPPSHRLT AKEVFDNDGK PRVDILKAHL MKEGRLEESV
     ALRIITEGAS ILRQEKNLLD IDAPVTVCGD IHGQFFDLMK LFEVGGSPAN TRYLFLGDYV
     DRGYFSIECV LYLWALKILY PKTLFLLRGN HECRHLTEYF TFKQECKIKY SERVYDACMD
     AFDCLPLAAL MNQQFLCVHG GLSPEINTLD DIRKLDRFKE PPAYGPMCDI LWSDPLEDFG
     NEKTQEHFTH NTVRGCSYFY SYPAVCEFLQ HNNLLSILRA HEAQDAGYRM YRKSQTTGFP
     SLITIFSAPN YLDVYNNKAA VLKYENNVMN IRQFNCSPHP YWLPNFMDVF TWSLPFVGEK
     VTEMLVNVLN ICSDDELGSE EDGFDGATAA ARKEVIRNKI RAIGKMARVF SVLREESESV
     LTLKGLTPTG MLPSGVLSGG KQTLQSATVE AIEADEAIKG FSPQHKITSF EEAKGLDRIN
     ERMPPRRDAM PSDANLNSIN KALTSETNGT DSNGSNSSNI Q
//
